The European Patent Office declared a patent owned by CureVac valid, after a challenge from drugmaker BioNTech, the company said on Thursday. U.S.-listed shares of Germany-based CureVac rose 11.8% in ...

Cleantech leader Aymium defeated a challenge by Stora Enso to one of Aymium's patents (European Patent EP2697185) that provides exclusive rights to produce, sell and use bio-based materials for ...

On Tuesday, the European Patent Office (EPO) published the Patent Index 2024, the latest edition of the EU patent agency’s ...

The European Patent Office’s latest report shows patent filings holding steady, with computer technology leading growth.

according to the annual Patent Index published on Tuesday by the European Patent Office (EPO). The EPO registered 199,264 ...

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

MUNICH, March 31, 2025 /PRNewswire/ -- The European Patent Office (EPO) published its annual Patent Index 2024 today, revealing that a total of 199,264 European patent applications were filed last ...

(Yicai) March 28 -- Chinese companies maintained a strong momentum in European patent applications last year, with battery ...

Germany-headquartered CureVac (Nasdaq: CVAC) late Thursday announced that the European Patent Office (EPO) has confirmed the ...

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...

European Patent Office received nearly 200 000 patent applications last year, with 10.1% coming from China; China ranks 4th globally in European patent applications; Huawei is No.

March 27 (Reuters) - The European Patent Office declared a patent owned by CureVac (5CV.DE), opens new tab, valid, after a challenge from drugmaker BioNTech (22UAy.DE), opens new tab, the company ...